These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
314 related items for PubMed ID: 36449252
1. New quantitative indices of cardiac amyloidosis with 99mTc-pyrophosphate scintigraphy. Matsuda N, Otsuka H, Otani T, Azane S, Kunikane Y, Otomi Y, Ueki Y, Kubota M, Amano M, Yagi S, Sata M, Harada M. Jpn J Radiol; 2023 Apr; 41(4):428-436. PubMed ID: 36449252 [Abstract] [Full Text] [Related]
2. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS. JAMA Cardiol; 2016 Nov 01; 1(8):880-889. PubMed ID: 27557400 [Abstract] [Full Text] [Related]
6. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with 99m Technetium Pyrophosphate Planar Imaging and Opportunities for Standardization of Diagnostic Workflow. Saleem M, Sadat B, Van Harn M, Ananthasubramaniam K. Medicina (Kaunas); 2023 Feb 16; 59(2):. PubMed ID: 36837580 [Abstract] [Full Text] [Related]
8. Diagnostic value of heart-to-mediastinum ratio in 99mTc-pyrophospate SPECT/CT for transthyretin cardiac amyloidosis. Ikoma T, Ohtani H, Ohno K, Iguchi K, Suwa K, Sawada M, Tanahashi Y, Sakamoto A, Saotome M, Ichikawa S, Goshima S, Maekawa Y. J Nucl Cardiol; 2023 Aug 16; 30(4):1374-1381. PubMed ID: 36547805 [Abstract] [Full Text] [Related]
18. Transthyretin amyloid cardiomyopathy disease burden quantified using 99mTc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours. Watanabe S, Nakajima K, Toshima F, Wakabayashi H, Yoshida S, Yoneyama H, Komatsu J, Konishi T, Kinuya S. J Nucl Cardiol; 2023 Dec 16; 30(6):2721-2735. PubMed ID: 37605060 [Abstract] [Full Text] [Related]
19. Assessment of cardiac amyloidosis with 99mTc-pyrophosphate (PYP) quantitative SPECT. Ren C, Ren J, Tian Z, Du Y, Hao Z, Zhang Z, Fang W, Li F, Zhang S, Hsu B, Huo L. EJNMMI Phys; 2021 Jan 07; 8(1):3. PubMed ID: 33411102 [Abstract] [Full Text] [Related]
20. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era. Martyn T, Saef J, Hussain M, Ives L, Kiang A, Estep JD, Collier P, Starling RC, Cremer PC, Tang WHW, Hanna M, Jaber WA. J Card Fail; 2022 Oct 07; 28(10):1509-1518. PubMed ID: 35843490 [Abstract] [Full Text] [Related] Page: [Next] [New Search]